JBIO

Jade Biosciences, Inc. Common Stock

75 hedge funds and large institutions have $57.8M invested in Jade Biosciences, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 19 reducing their positions, and 19 closing their positions.

Holders
75
Holders Change
-6
Holders Change %
-7.41%
% of All Funds
1.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
23
Reduced
19
Closed
19
Calls
$301K
Puts
$66K
Net Calls
+$235K
Net Calls Change
-$6K
Name Market Value Shares Shares
Change
Shares
Change %
WAM
76
Warberg Asset Management
Illinois
-67,449 Closed
Squarepoint
77
Squarepoint
New York
-57,082 Closed
A
78
AlphaQuest
New York
-32,856 Closed
CSS
79
Cubist Systematic Strategies
Connecticut
-31,894 Closed
PFS
80
Prospera Financial Services
Texas
-23,919 Closed
XT
81
XTX Topco
Cayman Islands
-21,143 Closed
GS
82
GTS Securities
New York
-20,673 Closed
PL
83
Parkwood LLC
Ohio
-18,467 Closed
VFA
84
Values First Advisors
Tennessee
-15,381 Closed
GGV
85
GG Group Ventures
Florida
-13,089 Closed
AG
86
Algert Global
California
-12,715 Closed
CM
87
Caption Management
Oklahoma
-7,000 Closed
Qube Research & Technologies (QRT)
88
Qube Research & Technologies (QRT)
United Kingdom
-3,453 Closed
FFO
89
Fortitude Family Office
Arizona
-416 Closed
GI
90
GAMMA Investing
California
-80 Closed
Osaic Holdings
91
Osaic Holdings
Arizona
-69 Closed
PNC Financial Services Group
92
PNC Financial Services Group
Pennsylvania
-11 -100%
CFGS
93
Concourse Financial Group Securities
Alabama
LP
94
LMR Partners
United Kingdom
MIM
95
MetLife Investment Management
New Jersey
Citadel Advisors
96
Citadel Advisors
Florida
FLC
97
Fifth Lane Capital
Texas
CF
98
Cantor Fitzgerald
New York
QL
99
Quarry LP
New York
CAL
100
Capital Advisors Ltd
Ohio
$0 8 +8